Clinical Trial Update: The Efficacy and Safety of Tacrolimus in Treated Refractory Focal Segmental Glomerulosclerosis [NA]

View source ↗

Summary

A clinical trial evaluating tacrolimus for treated refractory focal segmental glomerulosclerosis has been terminated. The update notes the trial status and does…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Segmental Glomerulosclerosis

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Nanjing University School of Medicine | Conditions: FSGS | NA | Status: TERMINATED